The Pharmacokinetics of ZiprasidoneTANDON, R.British journal of clinical pharmacology. Supplement. 2000, Vol 49, Num 1, issn 0264-3774, 78 p.Serial Issue

Ziprasidone in the Treatment of Affective Disorders : A ReviewROSA, Adriane R; FRANCO, Carolina; TORRENT, Carla et al.CNS neuroscience & therapeutics (Print). 2008, Vol 14, Num 4, pp 278-286, issn 1755-5930, 9 p.Article

Development and Validation of an HPLC Method for Determination of Ziprasidone and Its Impurities in Pharmaceutical Dosage Forms : New methods for Drug Analysis in Biological Samples and Other MatrixesPAVLOVIC, Marija; MALESEVIC, Marija; NIKOLIC, Katarina et al.Journal of AOAC International. 2011, Vol 94, Num 3, pp 713-722, issn 1060-3271, 10 p.Article

Ziprasidona intramuscular (I.M) na prática psiquiátrica = Ziprasidone intramuscular (I.M) in the clinical psychiatric practiceDA COSTA, Delcir Antonio; DE CASTRO E COSTA, Erico.Psiquiatria biológica (Belo Horizonte). 2004, Vol 12, Num 1, pp 11-13, issn 0104-7787, 3 p.Article

Neuroleptic malignant syndrome associated with ziprasidone in an adolescentLEIBOLD, Joseph; PATEL, Vipul; HASAN, Rashed A et al.Clinical therapeutics. 2004, Vol 26, Num 7, pp 1105-1108, issn 0149-2918, 4 p.Article

D₂-blockade and possible ziprasidone-induced galactorrheaRAMADAN, Mohamed; KHAN, Ahsan; PRESKORN, Sheldon et al.International clinical psychopharmacology. 2005, Vol 20, Num 2, pp 113-114, issn 0268-1315, 2 p.Article

Adolescent female with withdrawal psychosis following abrupt termination of ziprasidoneJACOB, Maryann K; ASH, Peter; EDWARD CRAIGHEAD, W et al.European child & adolescent psychiatry. 2012, Vol 21, Num 3, pp 165-168, issn 1018-8827, 4 p.Article

Clinical Global Impression of Improvement (CGI-I) as a valid proxy measure for remission in schizophrenia: Analyses of ziprasidone clinical study dataMASAND, Prakash; O'GORMAN, Cedric; MANDEL, Francine S et al.Schizophrenia research. 2011, Vol 126, Num 1-3, pp 174-183, issn 0920-9964, 10 p.Article

Electrocardiographic changes in children and adolescents treated with ziprasidone: A prospective studyBLAIR, Jennifer; SCAHILL, Lawrence; STATE, Matthew et al.Journal of the American Academy of Child and Adolescent Psychiatry. 2005, Vol 44, Num 1, pp 73-79, issn 0890-8567, 7 p.Article

Efficacy of atypical antipsychotics in mood disordersYATHAM, Lakshmi N.Journal of clinical psychopharmacology. 2003, Vol 23, Num 3, pp S9-S14, issn 0271-0749, SUP1Conference Paper

Ziprasidone-associated pedal edema in the treatment of schizophreniaKU, Hsiao-Lun; SU, Tung-Ping; CHOU, Yuan-Hwa et al.Progress in neuro-psychopharmacology & biological psychiatry. 2006, Vol 30, Num 5, pp 963-964, issn 0278-5846, 2 p.Article

Metabolism and excretion of the novel antipsychotic drug ziprasidone in rats after oral administration of a mixture of ¹⁴C- and ³H-labeled ziprasidonePRAKASH, C; KAMEL, A; ANDERSON, W et al.Drug metabolism and disposition. 1997, Vol 25, Num 2, pp 206-218, issn 0090-9556Article

Urticaria and angio-oedema due to ziprasidoneAKKAYA, Cengiz; SARANDOL, Asli; AYDOGAN, Kenan et al.Journal of psychopharmacology (Oxford). 2007, Vol 21, Num 5, pp 550-552, issn 0269-8811, 3 p.Article

Ziprasidone in the management of schizophrenia: The QT interval issue in contextTAYLOR, David.CNS drugs. 2003, Vol 17, Num 6, pp 423-430, issn 1172-7047, 8 p.Article

Effectiveness, tolerability, and safety of ziprasidone in patients with schizophrenia or schizoaffective disorder : Results of a multi-centre observational trialKUDLA, Duerten; LAMBERT, Martin; DOMIN, Sabine et al.European psychiatry. 2007, Vol 22, Num 3, pp 195-202, issn 0924-9338, 8 p.Article

Effectiveness, safety, and tolerability of ziprasidone for treating schizophrenia patients undergoing usual care : A 12-month, open-label, flexible-dose, naturalistic observational trialRATNER, Yael; GIBEL, Anatoly; YORKOV, Vladimir et al.Progress in neuro-psychopharmacology & biological psychiatry. 2007, Vol 31, Num 7, pp 1401-1409, issn 0278-5846, 9 p.Article

An exploratory open-label trial of ziprasidone for the treatment of behavioral and psychological symptoms of dementiaLOPES ROCHA, Fabio; HARA, Claudia; GUARIEIRO RAMOS, Melissa et al.Dementia and geriatric cognitive disorders. 2006, Vol 22, Num 5-6, pp 445-448, issn 1420-8008, 4 p.Article

Molecular Dynamics of the Cryomilled Base and Hydrochloride Ziprasidones by Means of Dielectric SpectroscopyKAMINSKI, K; ADRJANOWICZ, K; WOJNAROWSKA, Z et al.Journal of pharmaceutical sciences. 2011, Vol 100, Num 7, pp 2642-2657, issn 0022-3549, 16 p.Article

Ziprasidone-induced spontaneous orgasmBOORA, K; CHIAPPONE, K; DUBOVSKY, S et al.Journal of psychopharmacology (Oxford). 2010, Vol 24, Num 6, pp 947-948, issn 0269-8811, 2 p.Article

Efficacy and tolerability of ziprasidone in patients with treatment-resistant schizophreniaKANE, John M; KHANNA, Sumant; RAJADHYAKSHA, Sunita et al.International clinical psychopharmacology. 2006, Vol 21, Num 1, pp 21-28, issn 0268-1315, 8 p.Article

Use of ziprasidone in patients with schizophrenia in four European countriesMONTES, J.-M.European psychiatry. 2011, Vol 26, pp 29-37, issn 0924-9338, 9 p., NS1Article

Efficacy of ziprasidone in dysphoric mania: Pooled analysis of two double-blind studiesSTAHL, S; LOMBARDO, I; LOEBEL, A et al.Journal of affective disorders. 2010, Vol 122, Num 1-2, pp 39-45, issn 0165-0327, 7 p.Article

Prospective observational multi-poison center study of ziprasidone exposuresKLEIN-SCHWARTZ, Wendy; LOFTON, Amanda L; BENSON, Blaine E et al.Clinical toxicology (Philadelphia, Pa. Print). 2007, Vol 45, Num 7, pp 782-786, issn 1556-3650, 5 p.Article

The effectiveness of ziprasidone in treating impaired quality of life in schizophrenia : A 12-month, open-label, flexible-dose, naturalistic observational study of patients undergoing usual careRITSNER, Michael S; YORKOV, Vladimir; RATNER, Yael et al.Progress in neuro-psychopharmacology & biological psychiatry. 2007, Vol 31, Num 7, pp 1470-1477, issn 0278-5846, 8 p.Article

Effect of initial ziprasidone dose on length of therapy in schizophreniaJOYCE, Amie T; HARRISON, David J; LOEBEL, Antony D et al.Schizophrenia research. 2006, Vol 83, Num 2-3, pp 285-292, issn 0920-9964, 8 p.Article